Johnson & Johnson reports third-quarter results. Johnson & Johnson stock trades at EUR 235.38

Published on 10/24/2026 at 10:40 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

Johnson & Johnson stock trades at EUR 235.38 in weekend trading on October 24, 2026. The Xetra close on October 23, 2026 was EUR 235.05.

Quarterly results and trading levels

On October 13, 2026, Johnson & Johnson reported third-quarter sales of $25.4 billion.
Johnson & Johnson stock trades in weekend trading at Lang & Schwarz at EUR 235.38 at 10:36 a.m. CEST on October 24, 2026, 0.14 percent above the Xetra close of October 23, 2026.
The next Xetra session is scheduled for October 26, 2026.

Overhead flat lay on white Carrara marble of five healthcare items in a neat row: a beige adhesive bandage strip, a white sterile wound dressing pad, a plain white lotion bottle, a white pill organizer tray with round tablets, and a coiled silver stethosc — Johnson Consumer Health Produkte, US4781601046 Flatlay mit Pflaster Lotion Stethoskop auf Marmor, Illustration mit AI erstellt.

Johnson & Johnson reported third-quarter 2026 results on October 13, 2026, according to the company’s Investor Relations release. Johnson & Johnson stock was at EUR 235.38 in weekend trading at Lang & Schwarz at 10:36 a.m. CEST on October 24, 2026, up EUR 0.33, or 0.14 percent, versus the Xetra close of October 23, 2026 at EUR 235.05.

Weekend trading

The Lang & Schwarz bid was EUR 235.15 and the ask was EUR 235.60 at the stated time. The further course of weekend trading at Lang & Schwarz until 1:00 p.m. CET/CEST is shown by the continuously updated real-time quote of Johnson & Johnson stock.

The week in figures

The Xetra close of October 23, 2026 was EUR 235.05. The weekend indication from Lang & Schwarz was EUR 235.38, equivalent to 0.14 percent above that reference level. Xetra was closed during the weekend trading phase.

Chronology of the week

The latest dated company development in the reviewed period was Johnson & Johnson’s October 13, 2026 release on third-quarter results and higher full-year guidance. The company reported third-quarter sales of $25.4 billion and net earnings of $210 million. Adjusted diluted earnings per share were $2.59. The release raised the midpoint of estimated reported 2026 sales guidance to $101.2 billion and the midpoint of adjusted diluted earnings-per-share guidance to $11.10. These figures are reported in the company’s Investor Relations release.

Dates of the coming week

The next Xetra session is scheduled for October 26, 2026. Johnson & Johnson’s October 13, 2026 dividend announcement separately listed November 24, 2026 as the record and ex-dividend date and December 8, 2026 as the payment date, according to the company’s press release.

Market context: Market report S&P 500.